BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 + TB 500: what patients should know These peptides are increasingly discussed in regenerative and sports medicine due to early research in tissue repair and recovery pathwayswhich is why they've gained attention BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH MOTS c Dosage Protocol: The 4 Injection Cycle, Reconstitution Guide, and the Exact Schedule We Use Perfect B